BIOMAT Database Logo BIOMAT Database Logo

[Diagnostic value of atrial natriuretic peptide in hypertension and heart insufficiency]. 1987

T Jeck, and E Vogt, and R Oertel, and K Záruba, and A Schmid-Zumstein, and A Steiner, and M Knorr, and H Vetter, and W Vetter
Department für Innere Medizin, Medizinische Poliklinik, Universitätsspital, Zürich.

Serum ANP levels were measured by radioreceptor assay in 40 patients with various forms of secondary hypertension and 6 patients with heart failure. In addition, serum ANP was determined in 4 patients with renal artery stenosis before and after dilatation, as well as in 5 anephric patients before and after haemodialysis. Our results showed elevated serum ANP level in most patients with various forms of secondary hypertension and chronic heart failure. A distinction between these two groups and a control group of healthy individuals was not possible due to the wide range and occasional normal levels in the first two groups. ANP levels in patients with renal stenosis decreased after dilatation but there was no correlation with the success of this procedure. A positive correlation between ANP and plasma renin level was detectable in patients with renal artery stenosis, but was also elevated in anephric patients with absent renin production. In summary, our results show that measurements of serum-ANP are of little significance in the diagnosis of hypertension and chronic cardiac failure.

UI MeSH Term Description Entries
D006973 Hypertension Persistently high systemic arterial BLOOD PRESSURE. Based on multiple readings (BLOOD PRESSURE DETERMINATION), hypertension is currently defined as when SYSTOLIC PRESSURE is consistently greater than 140 mm Hg or when DIASTOLIC PRESSURE is consistently 90 mm Hg or more. Blood Pressure, High,Blood Pressures, High,High Blood Pressure,High Blood Pressures
D009320 Atrial Natriuretic Factor A potent natriuretic and vasodilatory peptide or mixture of different-sized low molecular weight PEPTIDES derived from a common precursor and secreted mainly by the HEART ATRIUM. All these peptides share a sequence of about 20 AMINO ACIDS. ANF,ANP,Atrial Natriuretic Peptide,Atrial Natriuretic Peptides,Atriopeptins,Auriculin,Natriuretic Peptides, Atrial,ANF (1-126),ANF (1-28),ANF (99-126),ANF Precursors,ANP (1-126),ANP (1-28),ANP Prohormone (99-126),ANP-(99-126),Atrial Natriuretic Factor (1-126),Atrial Natriuretic Factor (1-28),Atrial Natriuretic Factor (99-126),Atrial Natriuretic Factor Precursors,Atrial Natriuretic Factor Prohormone,Atrial Natriuretic Peptide (1-126),Atrial Pronatriodilatin,Atriopeptigen,Atriopeptin (1-28),Atriopeptin (99-126),Atriopeptin 126,Atriopeptin Prohormone (1-126),Cardiodilatin (99-126),Cardiodilatin Precursor,Cardionatrin I,Cardionatrin IV,Prepro-ANP,Prepro-CDD-ANF,Prepro-Cardiodilatin-Atrial Natriuretic Factor,Pro-ANF,ProANF,Proatrial Natriuretic Factor,Pronatriodilatin,alpha ANP,alpha-ANP Dimer,alpha-Atrial Natriuretic Peptide,beta-ANP,beta-Atrial Natriuretic Peptide,gamma ANP (99-126),gamma-Atrial Natriuretic Peptide,Natriuretic Peptide, Atrial,Peptide, Atrial Natriuretic,Peptides, Atrial Natriuretic,Prepro ANP,Prepro CDD ANF,Prepro Cardiodilatin Atrial Natriuretic Factor,Pro ANF,alpha ANP Dimer,alpha Atrial Natriuretic Peptide,beta ANP,beta Atrial Natriuretic Peptide,gamma Atrial Natriuretic Peptide
D011869 Radioligand Assay Quantitative determination of receptor (binding) proteins in body fluids or tissue using radioactively labeled binding reagents (e.g., antibodies, intracellular receptors, plasma binders). Protein-Binding Radioassay,Radioreceptor Assay,Assay, Radioligand,Assay, Radioreceptor,Assays, Radioligand,Assays, Radioreceptor,Protein Binding Radioassay,Protein-Binding Radioassays,Radioassay, Protein-Binding,Radioassays, Protein-Binding,Radioligand Assays,Radioreceptor Assays
D012078 Renal Artery Obstruction Narrowing or occlusion of the RENAL ARTERY or arteries. It is due usually to ATHEROSCLEROSIS; FIBROMUSCULAR DYSPLASIA; THROMBOSIS; EMBOLISM, or external pressure. The reduced renal perfusion can lead to renovascular hypertension (HYPERTENSION, RENOVASCULAR). Renal Artery Stenosis,Obstruction, Renal Artery,Obstructions, Renal Artery,Renal Artery Obstructions,Renal Artery Stenoses,Stenoses, Renal Artery,Stenosis, Renal Artery
D012083 Renin A highly specific (Leu-Leu) endopeptidase that generates ANGIOTENSIN I from its precursor ANGIOTENSINOGEN, leading to a cascade of reactions which elevate BLOOD PRESSURE and increase sodium retention by the kidney in the RENIN-ANGIOTENSIN SYSTEM. The enzyme was formerly listed as EC 3.4.99.19. Angiotensin-Forming Enzyme,Angiotensinogenase,Big Renin,Cryorenin,Inactive Renin,Pre-Prorenin,Preprorenin,Prorenin,Angiotensin Forming Enzyme,Pre Prorenin,Renin, Big,Renin, Inactive
D006333 Heart Failure A heterogeneous condition in which the heart is unable to pump out sufficient blood to meet the metabolic need of the body. Heart failure can be caused by structural defects, functional abnormalities (VENTRICULAR DYSFUNCTION), or a sudden overload beyond its capacity. Chronic heart failure is more common than acute heart failure which results from sudden insult to cardiac function, such as MYOCARDIAL INFARCTION. Cardiac Failure,Heart Decompensation,Congestive Heart Failure,Heart Failure, Congestive,Heart Failure, Left-Sided,Heart Failure, Right-Sided,Left-Sided Heart Failure,Myocardial Failure,Right-Sided Heart Failure,Decompensation, Heart,Heart Failure, Left Sided,Heart Failure, Right Sided,Left Sided Heart Failure,Right Sided Heart Failure
D006435 Renal Dialysis Therapy for the insufficient cleansing of the BLOOD by the kidneys based on dialysis and including hemodialysis, PERITONEAL DIALYSIS, and HEMODIAFILTRATION. Dialysis, Extracorporeal,Dialysis, Renal,Extracorporeal Dialysis,Hemodialysis,Dialyses, Extracorporeal,Dialyses, Renal,Extracorporeal Dialyses,Hemodialyses,Renal Dialyses
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D014511 Uremia A clinical syndrome associated with the retention of renal waste products or uremic toxins in the blood. It is usually the result of RENAL INSUFFICIENCY. Most uremic toxins are end products of protein or nitrogen CATABOLISM, such as UREA or CREATININE. Severe uremia can lead to multiple organ dysfunctions with a constellation of symptoms. Uremias

Related Publications

T Jeck, and E Vogt, and R Oertel, and K Záruba, and A Schmid-Zumstein, and A Steiner, and M Knorr, and H Vetter, and W Vetter
[Brain natriuretic peptide. Diagnostic value in heart failure].
January 2002, Revista espanola de cardiologia,
T Jeck, and E Vogt, and R Oertel, and K Záruba, and A Schmid-Zumstein, and A Steiner, and M Knorr, and H Vetter, and W Vetter
[Atrial natriuretic peptide in cardiac insufficiency].
February 1990, Cardiologia (Rome, Italy),
T Jeck, and E Vogt, and R Oertel, and K Záruba, and A Schmid-Zumstein, and A Steiner, and M Knorr, and H Vetter, and W Vetter
[Atrial natriuretic peptide in cardiac insufficiency].
March 1988, Arzneimittel-Forschung,
T Jeck, and E Vogt, and R Oertel, and K Záruba, and A Schmid-Zumstein, and A Steiner, and M Knorr, and H Vetter, and W Vetter
[Atrial natriuretic peptide and hypertension].
June 1989, Zhonghua xin xue guan bing za zhi,
T Jeck, and E Vogt, and R Oertel, and K Záruba, and A Schmid-Zumstein, and A Steiner, and M Knorr, and H Vetter, and W Vetter
[Atrial natriuretic factor in heart insufficiency].
September 1992, Presse medicale (Paris, France : 1983),
T Jeck, and E Vogt, and R Oertel, and K Záruba, and A Schmid-Zumstein, and A Steiner, and M Knorr, and H Vetter, and W Vetter
Corin, atrial natriuretic peptide and hypertension.
April 2009, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association,
T Jeck, and E Vogt, and R Oertel, and K Záruba, and A Schmid-Zumstein, and A Steiner, and M Knorr, and H Vetter, and W Vetter
[Atrial natriuretic peptide and arterial hypertension].
January 1989, Polski tygodnik lekarski (Warsaw, Poland : 1960),
T Jeck, and E Vogt, and R Oertel, and K Záruba, and A Schmid-Zumstein, and A Steiner, and M Knorr, and H Vetter, and W Vetter
Atrial natriuretic peptide in human hypertension.
May 1987, European heart journal,
T Jeck, and E Vogt, and R Oertel, and K Záruba, and A Schmid-Zumstein, and A Steiner, and M Knorr, and H Vetter, and W Vetter
[Brain natriuretic Peptide. Diagnostic and prognostic value in chronic heart failure].
October 2003, Medizinische Klinik (Munich, Germany : 1983),
T Jeck, and E Vogt, and R Oertel, and K Záruba, and A Schmid-Zumstein, and A Steiner, and M Knorr, and H Vetter, and W Vetter
Atrial natriuretic peptide and brain natriuretic peptide release in human essential hypertension.
January 2009, Clinical laboratory,
Copied contents to your clipboard!